MELIX DIAZ: Open Payments
NPI 1568124337 · JOHNSTON, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$271 in 10 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $521 · 2025 $271
Food & beverage: $271
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $158 |
| ABBVIE INC. | 2 | $34 |
| Ardelyx, Inc. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Lilly USA, LLC | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: Ozempic, QULIPTA, IBSRELA, TRELEGY ELLIPTA, Wegovy, KISUNLA, BREZTRI.
Industry payments across RI — which companies pay providers there.
